EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells

Marco Bertolini iD, Lorena Mendive-Tapia, Utsa Karmakar, Marc Vendrell iD

Journal of the American Chemical Society · 2024

DOI: 10.1021/jacs.4c12035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Marco Bertolini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, The University of Edinburgh, Edinburgh EH16 4UU, U.K. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, H2020 Marie Sklodowska-Curie Actions, H2020 European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance in B cell leukemia is characterized by the coexpression of CXCR5 and CXCR3 chemokine receptors, making it a valuable biomarker for patient stratification. Herein, we report a novel platform of activatable chemokines to selectively image drug-resistant leukemic B cells for the first time. The C-terminal derivatization of the human chemokines CXCL13 and CXCL10 with bioorthogonal tetrazine-BODIPY and BCN groups retained binding and internalization via their cognate CXCR5 and CXCR3 receptors and enabled rapid fluorescence labeling of CXCR5+ CXCR3+ resistant B cells─but not drug-susceptible leukemic cells─via intracellular chemokine ligation. This modular chemical approach offers a versatile strategy for real-time immunophenotyping of cell populations with distinct chemokine profiles and will accelerate the design of new precision medicine tools to advance personalized therapies in blood tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmHumansLeukemia, B-CellChemokinesCell Line, TumorBoron CompoundsMolecular Structure

Substanzen

ChemokinesBoron Compounds

Autor:innen und Institutionen

  • Centre for Inflammation Research, The University of Edinburgh, Edinburgh EH16 4UU, U.K.
  • IRR Chemistry Hub, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh EH16 4UU, U.K.

ORCID-Profile: Marco Bertolini, Marc Vendrell

Förderung

  • European Research Council
  • H2020 Marie Sklodowska-Curie Actions
  • H2020 European Research Council

Zitieren

APA

Bertolini, M., Mendive-Tapia, L., Karmakar, U., & Vendrell, M. (2024). Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c12035

Vancouver

Bertolini M, Mendive-Tapia L, Karmakar U, Vendrell M. Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c12035

BibTeX
@article{Bertolini2024,
  author = {Bertolini, Marco and Mendive-Tapia, Lorena and Karmakar, Utsa and Vendrell, Marc},
  title = {Chemo-Click: Receptor-Controlled and Bioorthogonal Chemokine Ligation for Real-Time Imaging of Drug-Resistant Leukemic B Cells},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  doi = {10.1021/jacs.4c12035}
}
Kostenlos starten →